| ALPRAZOLAM |
12-15 h |
0.5-1 mg three times a day |
8.50% |
L3 - Limited Data-Presumed Compatible |
| CLOBAZAM |
36-42 h |
20-30 mg daily |
4.38%-5.33% |
L3 - Limited Data-Presumed Compatible |
| CLONAZEPAM |
18-50 h |
0.5-1 mg three times a day |
2.80% |
L3 - Limited Data-Presumed Compatible |
| DIAZEPAM |
43 h |
2-10 mg 2-4 times per day as needed |
0.88%-7.14% |
L3 - Limited Data-Presumed Compatible |
| LORAZEPAM |
12 h |
1 mg two-three times a day as needed |
2.6% - 2.9% |
L3 - Limited Data-Presumed Compatible |
| MIDAZOLAM |
3 h |
1-2.5 mg IV (varies by indication and route of adminis- tration) |
0.63% |
L2 - Limited Data-Probably Compatible |
| OXAZEPAM |
8 h |
10-30 mg 3-4 times a day |
0.28%-1% |
L2 - Limited Data-Probably Compatible |
| TEMAZEPAM |
9.5-12.4 h |
7.5-30 mg daily |
|
L3 - Limited Data-Presumed Compatible |
| TRIAZOLAM |
1.5-5.5 h |
0.125-0.25 mg daily |
|
L3 - No Data-Presumed Compatible |
